Sk of disease progression and death and the poor predictive value of immunological markers in this age group (Prendergast 2012). For children aged 24 to 59 months (two to five years) current WHO guidelines recommend that clinical and immunological thresholds be used to identify those children aged 24 to 59 months who need to start cART (WHO 2010b). Specifically, treatment should be initiated for a
Exposed to autoradiography film. High-mannose moieties were preserved only in untreated virus confirming that PNGase F and endo H effectively cleaved high-mannose residues on GPs of HIV-EBOV virion-like particles. (EPS) Figure S4 Thermolysin treatment of HIV-EBOV GP abrogates enhancement of infection by rhMBL in a thermolysin-concentration dependent manner. We preincubated HIV-EBOV GP virion-like
Exposed to autoradiography film. High-mannose moieties were preserved only in untreated virus confirming that PNGase F and endo H effectively cleaved high-mannose residues on GPs of HIV-EBOV virion-like particles. (EPS) Figure S4 Thermolysin treatment of HIV-EBOV GP abrogates enhancement of infection by rhMBL in a thermolysin-concentration dependent manner. We preincubated HIV-EBOV GP virion-like
Ons (mannanbinding activity) and MBL C4 cleavage activity in sera from 35 healthy adult volunteers of Caucasian, Asian, Hispanic or AfricanAmerican ancestry (females, n = 20). The sample had a 3.7 log10 range of MBL concentrations (0?,424 ng/mL) that were strongly correlated with the concordant MBL C4 cleavage values (0?7,468 U/mL; r2 = 0.91). The sample included three individuals with homozygous
Ons (mannanbinding activity) and MBL C4 cleavage activity in sera from 35 healthy adult volunteers of Caucasian, Asian, Hispanic or AfricanAmerican ancestry (females, n = 20). The sample had a 3.7 log10 range of MBL concentrations (0?,424 ng/mL) that were strongly correlated with the concordant MBL C4 cleavage values (0?7,468 U/mL; r2 = 0.91). The sample included three individuals with homozygous